Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 51655-427

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 51655-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 427 53 Master Bottle Label Approval Rev A 09 20)

Label for Cyclobenzaprine Hydrochloride Tablets USP 5 mg from Northwind Health Company, LLC. The film-coated tablet package contains 10 tablets. The label includes storage instructions and regulatory information such as NDC 51655-427-53 and repackaging details by Northwind Pharmaceuticals.*

FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Chemical structure diagram of cyclobenzaprine hydrochloride showing its molecular framework and formula components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.